Officials with the FDA have approvedthe first generic robenacoxib injectable (Robenacoxib Injection; Cronus Pharma Specialties) for the control of postoperative pain and inflammation in canine and ...
A new study published in the journal of BMC Nephrology showed that subcutaneous and intravenous epoetin showed similar effectiveness in hemodialysis patients from China's southwest ...
One experimental injection helped mice and pigs heal after heart attack by boosting a protective heart hormone. (CREDIT: ...
Zacks Investment Research on MSN
NVO stock sheds nearly $50B in market cap in a month: Should you sell?
Novo Nordisk NVO shares have plunged 22% in the past month, wiping out nearly $50 billion in market capitalization. Following ...
Strong Operating Growth: Total revenue and operating income increased 15.9% in Q4 and 14.0% for the year, driven primarily by a $73.2 million net unrealized gain on Partner investments (2024 ? $47.3 ...
Risankizumab showed high rates of clinical remission and endoscopic response when administered as subcutaneous induction therapy for moderate to severe CD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results